Romain Vasseur

Gemcitabine‐induced epithelial‐mesenchymal transition‐like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal‐like phenotype

Mehdi El Amrani, François Corfiotti, Matthieu Corvaisier et al. · Molecular Carcinogenesis · 2019 · 59 citations

Medicine, Cell Biology, Oncology +17

The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells <i>via</i> hCNT1 transporter and multidrug-resistance associated protein MRP-2

Nicolas Skrypek, Romain Vasseur, Audrey Vincent et al. · Oncotarget · 2015 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

Identification of prognostic markers in diffuse midline gliomas H3K27M‐mutant

Charlotte Dufour, Romain Perbet, Pierre Leblond et al. · Brain Pathology · 2019 · 40 citations · Full text

Medicine, Molecular Genetics, Oncology +17

The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways

Romain Vasseur, Nicolas Skrypek, Bélinda Duchêne et al. · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 2015 · 35 citations · Full text

Medicine, Cancer Biology, Oncology +17

TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Phosphorylation on S727

V Drubay, Nicolas Skrypek, Lucie Cordiez et al. · Cancers · 2018 · 20 citations · Full text

Medicine, Cancer Biology, Oncology +17